Stuart Ellison

735 total citations
27 papers, 552 citations indexed

About

Stuart Ellison is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Stuart Ellison has authored 27 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 9 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Stuart Ellison's work include Lysosomal Storage Disorders Research (11 papers), Virus-based gene therapy research (6 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Stuart Ellison is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Virus-based gene therapy research (6 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Stuart Ellison collaborates with scholars based in United Kingdom, United States and Canada. Stuart Ellison's co-authors include Brian Bigger, Helen Parker, Yotis A. Senis, Antonio Trabalza, Steve P. Watson, Aiyin Liao, Jun Mori, Rachelle Donn, Rebecca Holley and Jing Zhu and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Brain.

In The Last Decade

Stuart Ellison

26 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Ellison United Kingdom 14 250 147 116 112 109 27 552
Tanya M. McLaughlin United States 8 317 1.3× 180 1.2× 51 0.4× 152 1.4× 75 0.7× 9 712
Wenke Seifert Germany 11 184 0.7× 81 0.6× 254 2.2× 313 2.8× 256 2.3× 16 716
Lonneke Haer‐Wigman Netherlands 18 353 1.4× 150 1.0× 180 1.6× 31 0.3× 208 1.9× 39 637
Andrew R. Cullinane United States 16 390 1.6× 55 0.4× 97 0.8× 157 1.4× 401 3.7× 20 824
Claire E. Hall United Kingdom 9 272 1.1× 73 0.5× 62 0.5× 196 1.8× 72 0.7× 10 623
Srikanth Reddy Janga United States 16 179 0.7× 287 2.0× 24 0.2× 104 0.9× 82 0.8× 27 750
Ralph Snodgrass United States 12 417 1.7× 55 0.4× 202 1.7× 239 2.1× 161 1.5× 17 863
Masato Yasumi Japan 13 316 1.3× 30 0.2× 103 0.9× 129 1.2× 37 0.3× 21 636
Fédor Svinartchouk France 13 396 1.6× 55 0.4× 58 0.5× 57 0.5× 173 1.6× 17 537
Reinhard Grausenburger Austria 14 702 2.8× 50 0.3× 195 1.7× 126 1.1× 92 0.8× 25 1.1k

Countries citing papers authored by Stuart Ellison

Since Specialization
Citations

This map shows the geographic impact of Stuart Ellison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Ellison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Ellison more than expected).

Fields of papers citing papers by Stuart Ellison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Ellison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Ellison. The network helps show where Stuart Ellison may publish in the future.

Co-authorship network of co-authors of Stuart Ellison

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Ellison. A scholar is included among the top collaborators of Stuart Ellison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Ellison. Stuart Ellison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ellison, Stuart, Karen Buckland, Spandan Kalra, et al.. (2024). Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapy. Molecular Therapy — Methods & Clinical Development. 32(2). 101271–101271. 4 indexed citations
3.
Ellison, Stuart, Aiyin Liao, Hélène F.E. Gleitz, et al.. (2023). Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy. Molecular Therapy — Methods & Clinical Development. 31. 101127–101127. 5 indexed citations
4.
Ellison, Stuart, Helen Parker, & Brian Bigger. (2023). Advances in therapies for neurological lysosomal storage disorders. Journal of Inherited Metabolic Disease. 46(5). 874–905. 28 indexed citations
5.
Jones, Simon, Rebecca Holley, Claire Booth, et al.. (2023). Sustained biochemical engraftment and early clinical outcomes following autologous stem cell gene therapy for mucopolysaccharidosis type IIIA. Molecular Genetics and Metabolism. 138(2). 107171–107171. 2 indexed citations
6.
Ellison, Stuart, Gabriella Forte, Claire O’Leary, et al.. (2023). Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type II. Human Gene Therapy. 35(7-8). 232–242. 2 indexed citations
7.
Jones, Simon, Adrian J. Thrasher, Claire Booth, et al.. (2021). Ex-vivo autologous stem cell gene therapy clinical trial for mucopolysaccharidosis type IIIA: Update on phase I/II clinical trial. Molecular Genetics and Metabolism. 132(2). S56–S57. 2 indexed citations
8.
Parker, Helen, Stuart Ellison, Rebecca Holley, et al.. (2020). Haematopoietic stem cell gene therapy with IL ‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA. EMBO Molecular Medicine. 12(3). e11185–e11185. 39 indexed citations
9.
Wynn, Robert, Brian Bigger, Adrian J. Thrasher, et al.. (2020). Ex-Vivo Autologous Stem Cell Gene Therapy Clinical Trial for Mucopolysaccharidosis Type IIIA: Trial in Progress - NCT04201405. Blood. 136(Supplement 1). 15–16. 6 indexed citations
10.
Ellison, Stuart, Aiyin Liao, Helen Parker, et al.. (2019). Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA. Molecular Therapy — Methods & Clinical Development. 13. 399–413. 39 indexed citations
11.
Holley, Rebecca, Stuart Ellison, Daniel Fil, et al.. (2017). Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy. Brain. 141(1). 99–116. 66 indexed citations
12.
Eleftheriadou, Ioanna, et al.. (2014). Specific Retrograde Transduction of Spinal Motor Neurons Using Lentiviral Vectors Targeted to Presynaptic NMJ Receptors. Molecular Therapy. 22(7). 1285–1298. 16 indexed citations
13.
14.
Ellison, Stuart, Antonio Trabalza, Veronica Tisato, et al.. (2013). Dose-dependent Neuroprotection of VEGF165 in Huntington's Disease Striatum. Molecular Therapy. 21(10). 1862–1875. 19 indexed citations
15.
Trabalza, Antonio, Christos Georgiadis, Ioanna Eleftheriadou, et al.. (2012). Venezuelan equine encephalitis virus glycoprotein pseudotyping confers neurotropism to lentiviral vectors. Gene Therapy. 20(7). 723–732. 12 indexed citations
16.
Carpentier, David C. J., et al.. (2011). Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein. Gene Therapy. 19(7). 761–774. 33 indexed citations
17.
Ellison, Stuart, Jun Mori, A. Barr, & Yotis A. Senis. (2010). CD148 enhances platelet responsiveness to collagen by maintaining a pool of active Src family kinases. Journal of Thrombosis and Haemostasis. 8(7). 1575–1583. 27 indexed citations
18.
Senis, Yotis A., Michael G. Tomlinson, Stuart Ellison, et al.. (2009). The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis. Blood. 113(20). 4942–4954. 104 indexed citations
19.
Donn, Rachelle, Stuart Ellison, Rebecca Lamb, et al.. (2008). Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic‐onset juvenile idiopathic arthritis. Arthritis & Rheumatism. 58(3). 869–874. 24 indexed citations
20.
Kudrin, Alex, Martin Scott, Steven M. Martin, et al.. (2006). Human Macrophage Migration Inhibitory Factor. Journal of Biological Chemistry. 281(40). 29641–29651. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanya M. McLaughlin Breakdown of academic impact, for papers by Wenke Seifert Breakdown of academic impact, for papers by Lonneke Haer‐Wigman Breakdown of academic impact, for papers by Andrew R. Cullinane Breakdown of academic impact, for papers by Claire E. Hall Breakdown of academic impact, for papers by Srikanth Reddy Janga Breakdown of academic impact, for papers by Ralph Snodgrass Breakdown of academic impact, for papers by Masato Yasumi Breakdown of academic impact, for papers by Fédor Svinartchouk Breakdown of academic impact, for papers by Reinhard Grausenburger
Rankless by CCL
2026